Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

HAE
Haemonetics Corporation
stock NYSE

At Close
Jun 2, 2025 3:59:57 PM EDT
68.81USD+1.625%(+1.10)639,149
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-67.71)0
After-hours
May 30, 2025 4:00:30 PM EDT
67.71USD-0.066%(-0.05)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
3.30B
CEO
Christopher Simon
Headquarters
Boston, Massachusetts, USA
Industry
Medical Instruments & Supplies
Last Split
Dec 3, 20122for1
Related
CERSBAXBDXJNJSYKTMOPKIMDTXLV
HAE Stats
Avg. Vol. 10 Day
482,385
Avg. Vol. 30 Day
551,833
Employees
3,136
Market Cap
3,304,945,325
Shares Out.
48,036,996
On/Off Exchange
57%/43%
6 Month Beta
0.70
1 Year Beta
0.66
2 Year Beta
0.71
3 Year Beta
0.73
52 Week Low
55.30
52 Week High
94.99
SMA50
63.86
SMA200
72.27
1 Week
+1.19%
1 Month
+7.75%
3 Month
+5.72%
6 Month
-19.31%
1 Year
-19.06%
2 Year
-21.93%
5 Year
-33.07%
Profile
haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn't need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right

HAE Stock Summary

Haemonetics Corporation (NYSE:HAE) stock price today is $68.81, and today's volume is 639,149. HAE is up 1.625% today. The 30 day average volume is 551,833. HAE market cap is 3.30B with 48,036,996 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC